Markus Essler

Title: Innovations by Inventor Markus Essler

Introduction

Markus Essler is a notable inventor based in La Jolla, CA. He has made significant contributions to the field of medical research, particularly in the development of targeted therapies. With a total of 2 patents, his work focuses on innovative methods for directing therapeutic agents to specific tissues.

Latest Patents

Essler's latest patents include groundbreaking inventions such as "Breast homing peptides and methods of identifying same using aminopeptidase P." This invention provides a method for directing a moiety to breast vasculature by administering a conjugate that contains a homing molecule selectively targeting breast vasculature. In one embodiment, the homing molecule is a peptide with the amino acid sequence PGPEGAG.

Another significant patent is "Collagen-binding molecules that selectively home to tumor vasculature and methods of using same." This invention offers a conjugate containing a therapeutic agent linked to a homing molecule that selectively binds to tumor vasculature and collagen. In this case, the homing peptide includes the amino acid sequence CREKA or its conservative variants.

Career Highlights

Markus Essler is affiliated with the Burnham Institute for Medical Research, where he conducts his research and develops his innovative ideas. His work has the potential to revolutionize targeted therapies in oncology and other medical fields.

Collaborations

Some of his notable coworkers include Erkki I Ruoslahti and Darren M Brown, who have collaborated with him on various research projects.

Conclusion

Markus Essler's contributions to medical research through his patents demonstrate his commitment to advancing targeted therapies. His innovative approaches have the potential to significantly impact patient care and treatment outcomes.